Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 26, 2021

SELL
$2.41 - $5.63 $84,350 - $197,050
-35,000 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$0.97 - $4.08 $33,950 - $142,800
35,000 New
35,000 $139,000
Q2 2019

Jul 22, 2019

SELL
$1.4 - $2.47 $111,294 - $196,355
-79,496 Closed
0 $0
Q1 2018

Apr 30, 2018

SELL
$3.15 - $4.16 $184,517 - $243,680
-58,577 Reduced 42.42%
79,496 $252,000
Q4 2017

Feb 01, 2018

BUY
$3.07 - $4.68 $423,884 - $646,181
138,073
138,073 $424,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $69.6M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.